Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT05600673

Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata

Conditions: Alopecia Areata

Sex: All

Ages: 16 Years – 55 Years

Phase: PHASE1, PHASE2

Enrollment: 30

Sponsor: Ahmed Hassan Nouh MD

Location: Egypt

Summary

The goal of this study is to evaluate the efficacy and safety of combined CO2 fractional laser with Bimatoprost 0.03% as novel treatment of alopecia areata.The main question to study is will the bimatoprost facilitate hair growth if added to fractional CO2 laser treatment in Alopecia areata.

Eligibility Criteria

Inclusion Criteria:Patients with alopecia areata of the scalp (multilocuolaris or single patch).Patient aged from 16- 55 years old in both sex.Other treatment wash out period is two months.Exclusion Criteria:Ophiasis pattern and other patterns of alopecia areata.Chronic diseases of liver, heart, kidney and bloodPregnant womenInfections of skin in site of intervention

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05600673). StuddyBuddy aggregates publicly available trial information.